Original paperCardiovascular pre-participation screening of young competitive athletes for prevention of sudden death in China
Introduction
The sudden, unexpected death of a young athlete is a tragedy unparalleled in sports. Fatal sport-related injuries can result from head and cervical spine trauma, but most sudden deaths in athletes are cardiac in origin.1, 2 A prospective population-based study in the Veneto Region of Italy reported an incidence of sudden death of 2.3 (2.62 in males and 1.07 in females) per 100,000 athletes per year from all causes, and of 2.1 per 100,000 athletes per year from cardiovascular diseases.3 The prevalence of these conditions varies according to ethnic background. Hypertrophic cardiomyopathy (HCM) has been reported to be the leading cause of sudden death in young competitive athletes, accounting for up to 40% of athletic field deaths in the USA;1, 4 Arrhythmogenic right ventricular dysplasia (ARVD) is the most common cause of sudden death among Italian athletes;5 In Germany, there is a high proportion of myocarditis.5 Recently, considerable interest has been raised regarding the role of pre-participation screening for early identification of those cardiovascular diseases which are responsible for athletic field deaths and for disqualification of athletes at risk, with the expectation that such a strategy may eventually prevent sudden death. In an effort to identify clinically silent cardiovascular diseases that increase the risk for sudden death, most states have mandated pre-participation screening.6, 7 But in China, we had little knowledge about the cause and epidemiology of SCD in young athletes. In order to prevent sudden death, the athletes were screened for the cardiovascular diseases before competition.
Section snippets
Selection of subjects
Between June 2005 and July 2005, 351 athletes from 21 sports were screened for the cardiovascular diseases in Jiangsu Province. The athletes were in full training at the time of evaluation. All athletes had taken part in the seven national sport meeting in China. The athletes were aged from 13 to 34 years; 170 were male (48.4%) and 181 were female (51.6%). All were Chinese Han population.
Clinical parameters
Body surface area (BSA) where calculations were made using the following formulae: BSA (m2) = 0.00659 height
Clinical parameters
Of the 170 male athletes, the mean age was 23.04 ± 3.80 years (13–33 years), while body surface area was 2.06 ± 0.28 m2 (1.25–2.81 m2), HR was 60.86 ± 8.56 beats min (40–88 beats min), the height was 180.51 ± 12.49 cm (140–203 cm), the weight was 73.72 ± 16.87 kg (31–130 kg). SBP was 119.2 ± 13.57 mmHg (96–180 mmHg), SDP was 74.80 ± 9.30 mmHg (58–110 mmHg); of the 181 female athletes, the mean age was 20.73 ± 4.14 years (14–34 years), while body surface area was 1.82 ± 0.21 m2 (1.25–2.67 m2), HR was 61.51 ± 8.67 beats min (40–85
Discussion
Cardiovascular screening of athletes is a challenging aspect of the pre-participation evaluation. Recently, the long QT syndrome, Brugada, syndrome, ARVD, pre-excitation syndromes, dilated cardiomyopathy, short QT syndrome, and even hypertrophic cardiomyopathy may be identified with the electrocardiogram. Overall, these conditions (including HCM) account for up to 60% of sudden deaths in young competitive athletes.11 Despite a number of previous observational surveys, the determinants and
Practical implications
- •
Pre-participation cardiovascular screening should pursue any history of cardiac symptoms or family history of premature cardiac disease, as well as abnormal cardiovascular physical findings.
- •
The 12-lead electrocardiogram and echocardiography should be considered and have the potential to enhance the sensitivity of the screening process for detection of cardiovascular diseases with risk of sudden death in athletes.
- •
Coaches, players and the medical team should be aware for the ambitious and
Acknowledgments
This work was supported by a grant from National Natural Science Foundation of China (30570745) and High Technology Program of Jiangsu Province in China (BG2003033).
References (26)
- et al.
Does sports activity enhance the risk of sudden death in adolescents and young adults?
J Am Coll Cardiol
(2003) - et al.
Risk of sudden cardiac death in young athletes: which screening strategies are appropriate?
Pediatr Clin N Am
(2004) - et al.
Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes
J Am Coll Cardiol
(2002) - et al.
ECG variants and cardiac arrhythmias in athletes: clinical relevance and prognostic importance
Am Heart J
(1990) - et al.
Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients
J Am Coll Cardiol
(1995) - et al.
American college of cardiology/European society of cardiology clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American college of cardiology foundation task force on clinical expert consensus documents and the European society of cardiology committee for practice guidelines
J Am Coll Cardiol
(2003) - et al.
Global left ventricular shape is not altered as a consequence of physiologic remodeling in highly trained athletes
Am J Cardio
(2000) - et al.
Sudden death in young competitive athletes: clinical, demographic, and pathological profiles
JAMA
(1996) - et al.
Nontraumatic sports death in high school and college athletes
Med Sci Sports Exerc
(1995) - et al.
Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy
Circulation
(1995)
Preparticipation screening for the detection of cardiovascular abnormalities that may cause sudden death in competitive athletes
Br J Sports Med
Eligibility recommendations for competitive athletes with cardiovascular abnormalities
36th Bethesda conference
J Am Coll Cardiol
Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus statement of the study group of sport cardiology of the working group of cardiac rehabilitation and exercise physiology and the working group of myocardial and pericardial diseases of the European society of cardiology
Eur Heart J
Cited by (25)
Preparticipation Evaluation
2020, Primary Care - Clinics in Office PracticeCitation Excerpt :Screening for predisposing conditions is difficult and limited by several coexisting issues: the low prevalence of cardiovascular diseases responsible for sudden death (SD) in the young population, the low risk of SD among those with the diseases, the large sizes of the populations proposed for screening, and the imperfection of the 12-lead ECG as a screening or diagnostic tool in this setting.65 A valid concern with ECG screening is the potential for costly second-tier follow-up testing (eg, ECHOs and MRI) while only detecting rare true-positive results.38,87–89 However, even if ECGs with false-positive results could be reduced to only 5% in the course of screening 10 million individuals (the estimated number of US competitive athletes), screening ECGs would nevertheless identify a formidable obstacle of 500,000 people who required further testing to exclude underlying heart disease and resolve eligibility for sports participants.
Electrocardiographic right and left bundle branch block patterns in athletes: Prevalence, pathology, and clinical significance
2015, Journal of ElectrocardiologyCitation Excerpt :Incomplete left bundle branch block is defined by a QRS duration ≥ 100 ms and < 120 ms in leads I, aVL, and V5 or V6[13]. Although mostly cross-sectional in design, there have been many studies evaluating the presence of ECG abnormalities in athletes [7,15–27]. It has been well established that IRBBB is common, particularly among endurance athletes [21].
Assessment of the 12-lead electrocardiogram as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 years of age): A scientific statement from the american heart association and the american college of cardiology
2014, Journal of the American College of CardiologyCitation Excerpt :Very few of these individuals would ultimately prove to have important disease with a risk for SD that required disqualification (113,237). Often ignored in this discussion is the importance of false-negative test results in the ECGs, which reflect low sensitivity (93,97,125,127,189,190). In the current environment, false-negative results can be expected in ≥10% of patients with HCM (the most common cause of SD in young people), with a significant proportion of these showing completely normal patterns (189).
Hypertrophic cardiomyopathy vs athlete's heart
2009, International Journal of CardiologyScreening for safe sports participation: Do for yourself what you tell your patients
2009, European Journal of Cardiovascular Prevention and RehabilitationThe athlete’s heart: insights from echocardiography
2023, Echo Research and Practice